MENU
PROCF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Procaps Group, S.A (PROCF) Ownership - Who owns Procaps Group, S.A?

Procaps Group SA is an integrated healthcare and pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical solutions, medicines, and hospital supplies... Show more

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.58B
P/E Ratio
2.20
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.57
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.18 USD as % of share price

Fundamentals

PROCF
Capitalization
2.58B
P/E Ratio
2.20
Risk (Beta)
-0.57
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.18%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
65.36
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
77.6K
Shares Outstanding - Current
2.3B
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
-52.137
View a ticker or compare two or three
PROCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details